XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.22.1

Compensation Related Costs, Share Based Payments | 3 Months Ended
--- | ---
Mar. 31, 2021
Share-based Payment Arrangement [Abstract] |
Share-based Payment Arrangement | SHARE-BASED COMPENSATION Share-Based Award Activity During the three months ended March 31, 2022, the Company granted stock awards (“SAs”) under its 2014 Omnibus Equity Incentive Plan to executive officers (“EOs”). The SAs granted to the EOs were 100% vested and non-forfeitable on the grant date. The fair value of the SAs granted to EOs was recorded as share-based compensation expense on the grant date. The Company withheld 46,415 shares of common stock from EOs, at a total cost of $1.1 million, to satisfy statutory minimum tax requirements upon grant of the SAs. 2021 Employee Stock Awards On March 1, 2021, the Company’s Board of Directors approved an incentive program for eligible employees to participate in the Company’s new Employee Performance Based Restricted Stock Awards Plan (the “PBRS Award Plan”). This plan is being offered pursuant to the Company’s 2014 Omnibus Equity Incentive Plan. The Company incurred de minimis share-based compensation expense and compensation expense related to these awards during the three months ended March 31, 2022 and 2021, respectively. 2022 Employee Stock Awards On March 1, 2022, the Company’s Board of Directors approved the issuance of restricted stock awards for eligible employees in accordance with the PBRS Award Plan. The Company incurred de minimis compensation expense related to these awards during the three months ended March 31, 2022. A summary of share-based awards activity during the three months ended March 31, 2022 is as follows:
| Number of Shares |  | Weighted Average Grant Date Fair Value per Share
| (in thousands) |
Nonvested, December 31, 2021 | 28 |  |  | $ | 23.21 |
Granted | 140 |  |  | $ | 22.08 |
Vested | (126) |  |  | $ | 21.94 |
Forfeited | — |  |  | $ | — |
Nonvested, March 31, 2022 | 42 |  |  | $ | 23.23 |
Stock Options A summary of stock options activity during the three months ended March 31, 2022 is as follows:
| Number of Shares |  | Weighted Average Exercise Price per Share |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value
| (in thousands) |  |  | (in years) |  | (in thousands)
Options outstanding, December 31, 2021 | 500 |  |  | $ | 7.49 |  |  |  |  |
Granted |  |  | — |  |  |  |  |
Exercised | — |  |  | — |  |  |  |  |
Forfeited | — |  |  | — |  |  |  |  |
Options outstanding, March 31, 2022 | 500 |  |  | $ | 7.49 |  |  | 2.58 |  | $ | 6,135 |
Options exercisable, March 31, 2022 | 500 |  |  | $ | 7.49 |  |  | 2.58 |  | $ | 6,135 |
Share-Based Compensation Expense Share-based compensation expense was $2.9 million and $2.6 million for the three months ended March 31, 2022 and 2021, respectively. Recognized tax benefit related to share-based compensation expense was $0.7 million and $0.6 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, the estimated total remaining unamortized share-based compensation expense related to unvested Restricted Stock Awards (“RSAs”), net of forfeitures, was $0.4 million, which is expected to be recognized over a weighted-average period of 1.5 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration